The determination of histamine in challenged human leukocyte preparations by high-performance liquid chromatography

Mast cell mediators in allergic inflammation and mastocytosis

Mast cells possess an array of potent inflammatory mediators capable of inducing acute symptoms after cell activation, including urticaria, angioedema, bronchoconstriction, diarrhea, vomiting, hypotension, cardiovascular collapse, and death in few minutes. In contrast, mast cells can provide an array of beneficial mediators in the setting of acute infections, cardiovascular diseases, and cancer. The balance between the detrimental and beneficial roles of mast cells is not completely understood. Although the symptoms of acute mast cell mediator release can be reversed with epinephrine, adrenergic agonists, and mediator blockers, the continued release of histamine, proteases, prostaglandins, leukotrienes, cytokines, and chemokines leads to chronic and debilitating disease, such as mastocytosis. Identification of the molecular factors and mechanisms that control the synthesis and release of mast cell mediators should benefit all patients with mast cell activation syndromes and mastocytosis.

Simultaneous determination of histamine and serotonin in mast cells by high-performance liquid chromatography

A sensitive and rapid high-performance liquid chromatographic method for the simultaneous determination of histamine and 5-hydroxytryptamine (serotonin) in supernatants and cellular extracts from mouse bone marrow-derived mast cells was developed. The described method is based on a precolumn derivatization of histamine and serotonin with o-phthaldialdehyde (OPA) and subsequent separation of the amine-OPA adducts with an analytical reversed-phase C18 column combined with fluorometric detection (excitation wavelength 360 nm, emission at 455 nm). The mobile phase was 0.02 M sodiumacetate buffer (pH 8) including 5 mM 1-octanesulfonic acid and 50% methanol. The detection limits for histamine and serotonin were 3.3 pmol and 6.9 pmol, respectively (signal-to-noise ratio 2:1). The variations of peak areas of repeatedly injected low or high amounts of amine standards were 23.3% or 6.9% (for 0.5 ng or 12.5 ng histamine) and 26.4% or 4.0% (for 5.0 ng or 250 ng serotonin) during an experimental period of 4 weeks. The variation of retention times over 2 days was 1.1% for histamine and 1.7% for serotonin. A perfect linear relationship of amine concentrations and peak areas was documented by correlation coefficients of r > 0.999 for both histamine (0.1-125 ng) and serotonin (0.5-250 ng).